Revenues: $13.2M (-14.8%) mainly due to the low transfer price to distributor Medtronic. Gross margin slipped to 56.1% from 69.4% a year ago.
Cash flow ops was ($6.5M) compared to ($7.4M) a year ago reflecting lower cash expenditures.
Loss/share was ($0.10), an improvement of $0.09. Non-GAAP loss/share was ($0.02), an improvement of $0.11.
Subscribe for full text news in your inbox